PreciseDx: Funding, Investors & Team (Oct 2026)
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by analyzing morphology features. This allows for more tailored treatment and improved outcomes for patients. Clinical teams can trust PreciseDx for valuable insights and practical information to guide treatment choices. By utilizing artificial intelligence and its Morphology Feature Array™, PreciseDx designs disease-specific tests that provide in-depth pathology information and risk profiles for patients, aiding in treatment decisions.
PreciseDx has raised $35.6M across 3 funding rounds on record, the most recent an undisclosed round of $3.7M announced in Oct 2026.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
PreciseDx Company Profile and Key Stats
Latest funding round on record: Oct 2026.
PreciseDx Funding Rounds
PreciseDx raised $20.7M in a Series B announced in Aug 2024.
10 months later, a Series B of $11.2M was announced in Jun 2025.
1.3 years later, an undisclosed round of $3.7M was announced in Oct 2026.
PreciseDx Investors
9 investors are recorded in total; the 5 named above are those the record identifies.
PreciseDx Founders and Leadership Team
Contact details for the PreciseDx team: 3 of 4 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →PreciseDx Funding Compared to Other Health Care Startups
PreciseDx's latest round of $3.7M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PreciseDx in Health Care and New York
Companies Similar to PreciseDx
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
PreciseDx Funding FAQs
What does PreciseDx do?
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by analyzing morphology features. This allows for more tailored treatment and improved outcomes for patients. Clinical teams can trust PreciseDx for valuable insights and practical information to guide treatment choices. By utilizing artificial intelligence and its Morphology Feature Array™, PreciseDx designs disease-specific tests that provide in-depth pathology information and risk profiles for patients, aiding in treatment decisions.
How much funding has PreciseDx raised?
PreciseDx has raised $35.6M across 3 rounds on record. The most recent is an undisclosed round of $3.7M announced in Oct 2026.
When did PreciseDx last raise funding?
PreciseDx's most recent funding round on record is an undisclosed round of $3.7M, announced in Oct 2026.
Who has invested in PreciseDx?
Investors on record for PreciseDx include LabCorp, Agilent Technologies, Quest Diagnostics, Merck Global Health Innovation Fund, Mount Sinai Health System. FundedIQ records 9 investors in total.
Who founded PreciseDx?
FundedIQ lists Gerardo Fernandez (Chief Scientific Officer and Founder), Jack Zeineh (Founder), Michael J. Donovan (Founder) at PreciseDx.
Who is the CEO of PreciseDx?
Eric Converse is listed as Chief Executive Officer at PreciseDx.
Where is PreciseDx headquartered?
PreciseDx is based in New York, United States.
How many employees does PreciseDx have?
PreciseDx is in the 11-50 employee band.
When was PreciseDx founded?
PreciseDx was founded in 2019.
How does PreciseDx's funding compare to other Health Care startups?
PreciseDx's latest round of $3.7M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's PreciseDx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PreciseDx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.